ArticleCancer discovery2026

A Circulating GPNMB-Based Multimodal Model Integrates Tumor-Immune Crosstalk to Predict Immunotherapy Response in Esophageal Cancer.

Liang Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.